Please assess the completion status of the following clinical trial:

Trial Title: Effect of Epinephrine/ Phenylephrine for Preventing the Postreperfusion Syndrome During Reperfusion in Liver Transplantation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~- adults scheduled to undergo liver transplantation~Exclusion Criteria:~- pediatric liver transplantation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- phenylephrine (Type: EXPERIMENTAL): 100 mcg of phenylephrine is administered at the time of reperfusion
- epinephrine (Type: EXPERIMENTAL): 10 mcg of epinephrine is administered iv at the time of reperfusion
- control (Type: PLACEBO_COMPARATOR): 10 ml of normal saline is administered at the time of reperfusion

Based on this trial design, predict the completion outcome and termination type (if applicable).